In the context of lipid metabolism, we identified an expression signature: ColoLipidGene (ABCA1 (ATP-Binding Cassette Subfamily-A Member), ACSL1 (Acyl-CoA Synthetase 1), AGPAT1 (1-Acylglycerol-3-Phosphate O-Acyltransferase 1) and SCD (Stearoyl-CoA-desaturase 1) genes) that predicts prognosis in CRC patients of stage II [8]. This evidence concerns the gene SCD and colorectal carcinoma.